Evidence map›Paper›PMID 27714504›Full record

ArticleIrish journal of medical science2017

Diabetic charcot neuroarthropathy: prevalence, demographics and outcome in a regional referral centre.

A O'Loughlin, E Kellegher, C McCusker, R Canavan

Abstract read
PubMed Publisher
In one paragraph

Article in Irish journal of medical science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Asymptomatic Charcot foot in longstanding diabetes.Surgery in practice and science · 2026
    Article
  4. Article
  5. Sonographic features of active Charcot neuro-osteoarthropathy: A case series.Diabetic medicine : a journal of the British Diabetic Association · 2025
    Article
  6. Observational
  7. Article
  8. Article
  9. Observational
  10. Review
  11. Controversies in the management of active Charcot neuroarthropathy.Therapeutic advances in endocrinology and metabolism · 2023
    Review
  12. Long-term follow-up of conservative treatment of Charcot feet.Archives of orthopaedic and trauma surgery · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

A O'LoughlinDepartment of Diabetes, St. Vincent's University Hospital, Dublin, Ireland. aonghus_o_loughlin@hotmail.com.
E KellegherDepartment of Podiatry, St. Vincent's University Hospital, Dublin, Ireland.
C McCuskerDepartment of Podiatry, St. Vincent's University Hospital, Dublin, Ireland.
R CanavanDepartment of Diabetes, St. Vincent's University Hospital, Dublin, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetic Charcot neuroarthropathy (DCN) is a devastating complication for people with diabetes mellitus. The failure to diagnose DCN and institute treatment in the acute phase leads to permanent deformity and significant morbidity. There is a paucity of data on the prevalence and characteristics of patients who have developed this complication of diabetes.

aimsTo determine the prevalence, clinical characteristics and outcomes of patients with DCN from 2006 to 2012.

methodsCase finding was performed by searching three independent lists for the period 2006-2012 including: SYNGO radiology database, HIPE database of hospital discharges, and, combined list from podiatry, endocrinology, vascular surgery and orthopaedic clinics. A consensus meeting with chart review was undertaken to confirm diagnosis of DCN. A proforma was completed from chart review to determine clinical characteristics, initial treatment and outcomes for patients with DCN.

resultsForty cases of DCN were identified, resulting in an estimated period prevalence of 0.3 %. The majority of patients were male (68 %); most patients had T2DM (73 %). Mean ± SD for age was 58 ± 10 years and mean duration of diabetes was 15 ± 9 years. In the acute phase of DCN, offloading was performed in 50 %. Bisphosphonates were administered to 5 % and surgery undertaken in 5 % of cases. 38 % of patients developed subsequent foot ulceration and 20 % required amputation.

conclusionsThis is the first prevalence estimate of DCN in Ireland. These data suggest diagnosis of DCN is missed in the acute phase. There exists a significant risk of diabetic foot ulceration and amputation with DCN.

Indexed as

AgedAmputation, SurgicalArthropathy, NeurogenicDiabetic FootDiabetic NeuropathiesFemaleHumansIrelandMaleMiddle AgedPrevalenceRadiographyReferral and ConsultationRetrospective StudiesAmputationCharcotDiabetes mellitusNeuroarthropathyUlceration

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.